Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology

Objective To investigate the associated factors of BRAF V600E gene mutation in patients classified as Bethesda I~V nodes by fine needle aspiration cytology (FNAC) but confirmed as papillary thyroid carcinoma (PTC) by postoperative histopathology. Methods A retrospective analysis was performed on the...

Full description

Bibliographic Details
Main Authors: ZHANG Guozhi, SHI Qiyun, BAO Yangqiu
Format: Article
Language:zho
Published: Editorial Office of Journal of Army Medical University 2022-12-01
Series:陆军军医大学学报
Subjects:
Online Access:http://aammt.tmmu.edu.cn/Upload/rhtml/202208012.htm
_version_ 1797974747867250688
author ZHANG Guozhi
SHI Qiyun
BAO Yangqiu
author_facet ZHANG Guozhi
SHI Qiyun
BAO Yangqiu
author_sort ZHANG Guozhi
collection DOAJ
description Objective To investigate the associated factors of BRAF V600E gene mutation in patients classified as Bethesda I~V nodes by fine needle aspiration cytology (FNAC) but confirmed as papillary thyroid carcinoma (PTC) by postoperative histopathology. Methods A retrospective analysis was performed on the clinical data of the patients with FNAC classification of Bethesda I~V but confirmed by postoperative histopathology as PTC who were treated in our hospital from June 2020 to June 2021. According to the results of BRAF V600E gene test in preoperative puncture specimens, the patients were divided into mutation positive group and negative group. The clinical data were compared between the 2 groups, and the indicators associated with BRAF V600E gene mutation were analyzed. Results Of the 127 enrolled patients, they were 27 males (21.26%) and 100 females (78.74%), with a mean age of 42.51 years (median age: 42 years). Eight-two patients (64.57%) harbored the BRAF V600E gene mutation, and 45 (35.43%) did not. Univariate analysis showed that there were significant differences in the capsular boundary, nodule morphology, abnormal cervical lymph nodes, TIRADS grade, FNAC class, and T-stage between the 2 groups (P < 0.05). Multivariate logistic regression analysis indicated that capsular boundary and abnormal cervical lymph nodes were independent influencing factors of BRAF V600E gene mutation in these patients. ROC curve analysis suggested that the area under the curve (AUC) was 0.921 (95%CI: 0.876~0.967), with a sensitivity and specificity of 82.9% and 86.7%, respectively, when taking capsular boundary, nodule morphology, abnormal cervical lymph nodes and TIRADS grade combined together. Conclusion BRAF V600E gene mutation is associated with capsular boundary, nodule morphology, abnormal cervical lymph nodes on ultrasonogram, TIRADS grade, FNAC class, and T-stage in PTC patients. Among them, ultrasonographic indication of abnormal cervical lymph nodes and the boundary between nodules and capsule can be used to predict BRAF V600E gene mutation.
first_indexed 2024-04-11T04:23:31Z
format Article
id doaj.art-1e10694c380c4b148e13453f71c72203
institution Directory Open Access Journal
issn 2097-0927
language zho
last_indexed 2024-04-11T04:23:31Z
publishDate 2022-12-01
publisher Editorial Office of Journal of Army Medical University
record_format Article
series 陆军军医大学学报
spelling doaj.art-1e10694c380c4b148e13453f71c722032022-12-30T03:06:17ZzhoEditorial Office of Journal of Army Medical University陆军军医大学学报2097-09272022-12-0144242523252910.16016/j.2097-0927.202208012Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytologyZHANG Guozhi0SHI Qiyun1BAO Yangqiu2Department of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, ChinaDepartment of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, ChinaDepartment of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, ChinaObjective To investigate the associated factors of BRAF V600E gene mutation in patients classified as Bethesda I~V nodes by fine needle aspiration cytology (FNAC) but confirmed as papillary thyroid carcinoma (PTC) by postoperative histopathology. Methods A retrospective analysis was performed on the clinical data of the patients with FNAC classification of Bethesda I~V but confirmed by postoperative histopathology as PTC who were treated in our hospital from June 2020 to June 2021. According to the results of BRAF V600E gene test in preoperative puncture specimens, the patients were divided into mutation positive group and negative group. The clinical data were compared between the 2 groups, and the indicators associated with BRAF V600E gene mutation were analyzed. Results Of the 127 enrolled patients, they were 27 males (21.26%) and 100 females (78.74%), with a mean age of 42.51 years (median age: 42 years). Eight-two patients (64.57%) harbored the BRAF V600E gene mutation, and 45 (35.43%) did not. Univariate analysis showed that there were significant differences in the capsular boundary, nodule morphology, abnormal cervical lymph nodes, TIRADS grade, FNAC class, and T-stage between the 2 groups (P < 0.05). Multivariate logistic regression analysis indicated that capsular boundary and abnormal cervical lymph nodes were independent influencing factors of BRAF V600E gene mutation in these patients. ROC curve analysis suggested that the area under the curve (AUC) was 0.921 (95%CI: 0.876~0.967), with a sensitivity and specificity of 82.9% and 86.7%, respectively, when taking capsular boundary, nodule morphology, abnormal cervical lymph nodes and TIRADS grade combined together. Conclusion BRAF V600E gene mutation is associated with capsular boundary, nodule morphology, abnormal cervical lymph nodes on ultrasonogram, TIRADS grade, FNAC class, and T-stage in PTC patients. Among them, ultrasonographic indication of abnormal cervical lymph nodes and the boundary between nodules and capsule can be used to predict BRAF V600E gene mutation. http://aammt.tmmu.edu.cn/Upload/rhtml/202208012.htmpapillary thyroid carcinomabethesda i-v thyroid nodulesbraf v600e gene mutationfine needle aspiration cytologyassociated factors
spellingShingle ZHANG Guozhi
SHI Qiyun
BAO Yangqiu
Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
陆军军医大学学报
papillary thyroid carcinoma
bethesda i-v thyroid nodules
braf v600e gene mutation
fine needle aspiration cytology
associated factors
title Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
title_full Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
title_fullStr Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
title_full_unstemmed Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
title_short Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
title_sort factors associated with braf v600e gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
topic papillary thyroid carcinoma
bethesda i-v thyroid nodules
braf v600e gene mutation
fine needle aspiration cytology
associated factors
url http://aammt.tmmu.edu.cn/Upload/rhtml/202208012.htm
work_keys_str_mv AT zhangguozhi factorsassociatedwithbrafv600egenemutationinpatientswithundiagnosedpapillarythyroidcarcinomabyfineneedleaspirationcytology
AT shiqiyun factorsassociatedwithbrafv600egenemutationinpatientswithundiagnosedpapillarythyroidcarcinomabyfineneedleaspirationcytology
AT baoyangqiu factorsassociatedwithbrafv600egenemutationinpatientswithundiagnosedpapillarythyroidcarcinomabyfineneedleaspirationcytology